These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7113729)

  • 1. Studies on the physical properties of tablets and tablet excipients. V. Film coating for protection of a light-sensitive tablet-formulation.
    Nyqvist H; Nicklasson M; Lundgren P
    Acta Pharm Suec; 1982; 19(3):223-8. PubMed ID: 7113729
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the physical properties of tablets and tablet excipients. IV. A program for accelerated light stability testing.
    Nyqvist H; Nicklasson M; Lundgren P; Fyhr AS; Stjernfelt U
    Acta Pharm Suec; 1982; 19(2):91-8. PubMed ID: 7102355
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the physical properties of tablets and tablet excipients. II. Testing of light stability of tablets.
    Nyqvist H; Lundgren P; Jansson I
    Acta Pharm Suec; 1980; 17(3):148-56. PubMed ID: 7468234
    [No Abstract]   [Full Text] [Related]  

  • 4. Photoreactivity of biologically active compounds. XVIII. Photostability of ofloxacin in the solid state and in a tablet formulation.
    Tønnesen HH; Brunsvik A; Løseth K; Bergh K; Gederaas OA
    Pharmazie; 2007 Feb; 62(2):105-11. PubMed ID: 17341028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of excipients and technological process on cholecalciferol stability and its liberation from tablets.
    Sawicka J
    Pharmazie; 1991 Jul; 46(7):519-21. PubMed ID: 1664519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factorial design of experiment for stability studies in the development of a tablet formulation.
    El-Banna HM; Ismail AA; Gadalla MA
    Pharmazie; 1984 Mar; 39(3):163-5. PubMed ID: 6728887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation.
    Suñé-Negre JM; Pérez-Lozano P; Miñarro M; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Ticó JR
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1029-39. PubMed ID: 18367387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of water disinfectant tablets for rural communities in Nigeria.
    Sridhar MK; Jaiyeoba KT; Ashefor HO
    Afr J Med Med Sci; 1994 Jun; 23(2):181-5. PubMed ID: 7625309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
    Aryal S; Skalko-Basnet N
    Acta Pharm; 2008 Sep; 58(3):299-308. PubMed ID: 19103566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terahertz pulsed imaging as an analytical tool for sustained-release tablet film coating.
    Ho L; Müller R; Gordon KC; Kleinebudde P; Pepper M; Rades T; Shen Y; Taday PF; Zeitler JA
    Eur J Pharm Biopharm; 2009 Jan; 71(1):117-23. PubMed ID: 18647650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods.
    Thumma S; Repka MA
    Pharmazie; 2009 Mar; 64(3):183-9. PubMed ID: 19348341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raman spectroscopy of coated pharmaceutical tablets and physical models for multivariate calibration to tablet coating thickness.
    Kauffman JF; Dellibovi M; Cunningham CR
    J Pharm Biomed Anal; 2007 Jan; 43(1):39-48. PubMed ID: 16860508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of microorganisms in some common excipients used in tablet formulation.
    Obuekwe IF; Eichie F
    Acta Pol Pharm; 2006; 63(2):121-5. PubMed ID: 17514875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of the tablets coated with the novel formulation termed thin-layer sugarless coated tablets.
    Ohmori S; Ohno Y; Makino T; Kashihara T
    Int J Pharm; 2004 Jul; 278(2):459-69. PubMed ID: 15196649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To Maintain Formulation Composition Similarity of Coated Tablets of Different Strengths: Should Coating be Based on Core Tablet Weight or Surface Area?
    Reddy JP; Vyas G; Patel R; Rana S; Mansuri N; Dimuthu J; Shah T; Desai D
    Pharm Res; 2020 Sep; 37(10):201. PubMed ID: 32968862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a rapidly dispersing tablet of a poorly wettable compound: formulation DOE and mechanistic study of effect of formulation excipients on wetting of celecoxib.
    He X; Barone MR; Marsac PJ; Sperry DC
    Int J Pharm; 2008 Apr; 353(1-2):176-86. PubMed ID: 18207339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
    Zannou EA; Ji Q; Joshi YM; Serajuddin AT
    Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An active film-coating approach to enhance chemical stability of a potent drug molecule.
    Desai D; Rao V; Guo H; Li D; Stein D; Hu FY; Kiesnowski C
    Pharm Dev Technol; 2012; 17(2):227-35. PubMed ID: 21073265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.